Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma.
Saved in:
| Title: | Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma. |
|---|---|
| Authors: | Corrie, P. G.1 (AUTHOR) pippa.corrie@addenbrookes.nhs.uk, Qian, W.1 (AUTHOR), Basu, B.1,2 (AUTHOR), Valle, J. W.3 (AUTHOR), Falk, S.4 (AUTHOR), lwuji, C.5 (AUTHOR), Wasan, H.6 (AUTHOR), Palmer, D.7 (AUTHOR), Scott-Brown, M.8 (AUTHOR), Wadsley, J.9 (AUTHOR), Arif, S.10 (AUTHOR), Bridgewater, J.11 (AUTHOR), Propper, D.12 (AUTHOR), Gillmore, R.13 (AUTHOR), Gopinathan, A.2 (AUTHOR), Skells, R.1 (AUTHOR), Bundi, P.1 (AUTHOR), Brais, R.1 (AUTHOR), Dalchau, K.1 (AUTHOR), Bax, L.1 (AUTHOR) |
| Source: | British Journal of Cancer. Jun2020, Vol. 122 Issue 12, p1760-1768. 9p. 3 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/s41416-020-0846-2 |
